Cenobamate

Brand name: Xcopri

Rank #261 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$47.6M

Total Cost

Share:

33,831

Total Claims

$47.6M

Total Cost

779

Prescribers

$1,406

Cost per Claim

2,242

Beneficiaries

36,653

30-Day Fills

$61K

Avg Cost/Provider

43

Avg Claims/Provider

Share of Medicare Part D Spending

0.02%

of total Medicare Part D spending

$47.6M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $47.6M total

🔎 Data Overview

💰

At $1,406 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

👤

Average cost of $21,210 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Cenobamate

#ProviderSpecialtyLocationClaimsCost
1Jessica BishopPhysician AssistantBoise, ID778$1.2M
2Kelly Pearson-CaravettaNurse PractitionerPhiladelphia, PA546$910K
3Gregory ConnorNeurologyTulsa, OK661$906K
4Toufic FakhouryNeurologyLexington, KY477$679K
5Jorge AsconapeNeurologyOakbrook Terrace, IL356$574K
6Deborah ZielinskiNurse PractitionerChicago, IL387$567K
7Michael DohertyNeurologySeattle, WA349$524K
8Gregory KraussNeurologyBaltimore, MD149$405K
9Jong Woo LeeNeurologyBoston, MA179$404K
10Victor BitonNeurologyLittle Rock, AR306$380K
11Tricia KingNurse PractitionerMiami, FL232$378K
12Michael SperlingNeurologyPhiladelphia, PA197$377K
13Jason BispingNeurologyColumbus, OH299$370K
14Deborah RisbrookNurse PractitionerNew Hyde Park, NY261$370K
15Blanca VazquezNeurologyNew York, NY252$369K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
258Sucralfate (Sucralfate)$48.5M689,007
259Diroximel Fumarate (Vumerity)$48.5M5,351
260Cabotegravir/Rilpivirine (Cabenuva)$48.1M7,384
261Cenobamate (Xcopri)$47.6M33,831
262Clozapine (Clozapine)$47.0M491,951
263Pembrolizumab (Keytruda)$46.9M3,947
264Glipizide (Glipizide)$46.9M2,961,035

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology